NCT02487914

Brief Summary

Drug delivery is conducted through various methods such as injection, phonophoresis, and iontophoresis. Iontophoresis is defined as the noninvasive delivery of active ions through epidermis using direct current. The direct current has some disadvantages such as skin burning and limited time of application. Interferential current is a kind of alternating currents without limitations of direct current; so the purpose of this study was to investigate and compare the effects of Lidocaine, interferential current and Lidocaine iontophoresis using interferential current.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jan 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 15, 2015

Completed
17 days until next milestone

First Posted

Study publicly available on registry

July 2, 2015

Completed
Last Updated

July 2, 2015

Status Verified

June 1, 2015

Enrollment Period

1.2 years

First QC Date

June 15, 2015

Last Update Submit

July 1, 2015

Conditions

Keywords

Drug DeliveryIontophoresisLidocainePressureTactile perception

Outcome Measures

Primary Outcomes (1)

  • pain threshold- evaluated by increasing intensity of interferential current.

    pain threshold to increasing intensity of interferential current.

    up to one week

Secondary Outcomes (2)

  • tactile threshold- evaluated by exact perception of the lowest level of interferential current

    up to one week

  • pressure threshold- evaluated by Pesula

    up to one week

Study Arms (3)

lidocaine iontophoresis using interferential current

ACTIVE COMPARATOR

the threshold of pressure, tactile,and pain thresholds were evaluated after the iontophoresis of Lidocaine using interferential current.

Device: iontophoresis of Lidocaine 10% with interferential current (Dynatron 438)

interferential current

ACTIVE COMPARATOR

the threshold of pressure, tactile,and pain thresholds were evaluated after the application of interferential current.

Device: interferential current

lidocaine

ACTIVE COMPARATOR

the threshold of pressure, tactile,and pain thresholds were evaluated after the application of topical Lidocaine.

Drug: Lidocaine 10% was sprayed at the identified region

Interventions

drug delivery through interferential current.

Also known as: Dynatron 438, Enraf Nonius Comp., Netherlands
lidocaine iontophoresis using interferential current
Also known as: Xylocaine 10% spray, AstraZeneca, Korea
lidocaine
Also known as: Dynatron 438, Enraf Nonius Comp., Netherlands
interferential current

Eligibility Criteria

Age18 Years - 25 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy women with age between 18 and 25 years old

You may not qualify if:

  • Systemic disorders,
  • neuro-muscular diseases such as diabetes and all forms of neuropathies,
  • and use of narcoleptic drugs which may contaminate the results.
  • Also, none of the participants were on their menstrual cycle.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Rehabilitation

Shiraz, Fars, 33669-71947, Iran

Location

Related Publications (23)

  • Baskurt F, Ozcan A, Algun C. Comparison of effects of phonophoresis and iontophoresis of naproxen in the treatment of lateral epicondylitis. Clin Rehabil. 2003 Feb;17(1):96-100. doi: 10.1191/0269215503cr588oa.

    PMID: 12617384BACKGROUND
  • Ebrahimi S, Abbasnia K, Motealleh A, Kooroshfard N, Kamali F, Ghaffarinezhad F. Effect of lidocaine phonophoresis on sensory blockade: pulsed or continuous mode of therapeutic ultrasound? Physiotherapy. 2012 Mar;98(1):57-63. doi: 10.1016/j.physio.2011.01.009.

    PMID: 22265386BACKGROUND
  • Gokoglu F, Findikoglu G, Yorgancoglu ZR, Okumus M, Ceceli E, Kocaoglu S. Evaluation of iontophoresis and local corticosteroid injection in the treatment of carpal tunnel syndrome. Am J Phys Med Rehabil. 2005 Feb;84(2):92-6. doi: 10.1097/01.phm.0000151942.49031.dd.

    PMID: 15668556BACKGROUND
  • Pal B, Morris J. Perceived risks of joint infection following intra-articular corticosteroid injections: a survey of rheumatologists. Clin Rheumatol. 1999;18(3):264-5. doi: 10.1007/s100670050098.

    PMID: 11206357BACKGROUND
  • Jadoul A, Bouwstra J, Preat V V. Effects of iontophoresis and electroporation on the stratum corneum. Review of the biophysical studies. Adv Drug Deliv Rev. 1999 Jan 4;35(1):89-105. doi: 10.1016/s0169-409x(98)00065-9.

    PMID: 10837691BACKGROUND
  • Jadoul A, Doucet J, Durand D, Preat V. Modifications induced on stratum corneum structure after in vitro iontophoresis; ATR-FTIR and X-ray scattering studies. J. Controlled Release 42: 165-173,1996.

    BACKGROUND
  • Thysman S, Van Neste D, Preat V. Noninvasive investigation of human skin after in vivo iontophoresis. Skin Pharmacol. 1995;8(5):229-36. doi: 10.1159/000211352.

    PMID: 8527154BACKGROUND
  • Costello CT, Jeske AH. Iontophoresis: applications in transdermal medication delivery. Phys Ther. 1995 Jun;75(6):554-63. doi: 10.1093/ptj/75.6.554.

    PMID: 7770500BACKGROUND
  • Singh P, Maibach HI. Iontophoresis in drug delivery: basic principles and applications. Crit Rev Ther Drug Carrier Syst. 1994;11(2-3):161-213.

    PMID: 7600587BACKGROUND
  • Panzade P, Puranik P. Iontophoresis: A Functional Approach for Enhancement of Transdermal Drug Delivery. Asian Journal of Biomedical and Pharmaceutical Sciences 2(11): 1-8, 2012.

    BACKGROUND
  • Banga AK, Chien YW. Hydrogel-based iontotherapeutic delivery devices for transdermal delivery of peptide/protein drugs. Pharm Res. 1993 May;10(5):697-702. doi: 10.1023/a:1018955631835.

    PMID: 8321834BACKGROUND
  • Gupta SK, Bernstein KJ, Noorduin H, Van Peer A, Sathyan G, Haak R. Fentanyl delivery from an electrotransport system: delivery is a function of total current, not duration of current. J Clin Pharmacol. 1998 Oct;38(10):951-8. doi: 10.1002/j.1552-4604.1998.tb04392.x.

    PMID: 9807977BACKGROUND
  • Lvovich VF, Matthews E, Riga AT, Kaza L. AC electrokinetic platform for iontophoretic transdermal drug delivery. J Control Release. 2010 Jul 14;145(2):134-40. doi: 10.1016/j.jconrel.2010.04.015. Epub 2010 Apr 24.

    PMID: 20420867BACKGROUND
  • Reinauer S, Neusser A, Schauf G, Holzle E. Iontophoresis with alternating current and direct current offset (AC/DC iontophoresis): a new approach for the treatment of hyperhidrosis. Br J Dermatol. 1993 Aug;129(2):166-9. doi: 10.1111/j.1365-2133.1993.tb03521.x.

    PMID: 7654577BACKGROUND
  • Ganne JM. Interferential therapy. Aust J Physiother. 1976 Sep;22(3):101-10. doi: 10.1016/S0004-9514(14)61005-9.

    PMID: 25026222BACKGROUND
  • Jorge S, Parada CA, Ferreira SH, Tambeli CH. Interferential therapy produces antinociception during application in various models of inflammatory pain. Phys Ther. 2006 Jun;86(6):800-8.

    PMID: 16737405BACKGROUND
  • Watson T. The role of electrotherapy in contemporary physiotherapy practice. Man Ther. 2000 Aug;5(3):132-41. doi: 10.1054/math.2000.0363.

    PMID: 11034883BACKGROUND
  • Bhatia G, Banga AK. Effect of modulated alternating and direct current iontophoresis on transdermal delivery of lidocaine hydrochloride. Biomed Res Int. 2014;2014:537941. doi: 10.1155/2014/537941. Epub 2014 May 15.

    PMID: 24959580BACKGROUND
  • Hayashi S, Ogami S, Shibaji T, Umino M. Lidocaine transport through a cellophane membrane by alternating current iontophoresis with a duty cycle. Bioelectrochemistry. 2009 Feb;74(2):315-22. doi: 10.1016/j.bioelechem.2008.11.007. Epub 2008 Nov 30.

    PMID: 19110474BACKGROUND
  • Yan G, Xu Q, Anissimov YG, Hao J, Higuchi WI, Li SK. Alternating current (AC) iontophoretic transport across human epidermal membrane: effects of AC frequency and amplitude. Pharm Res. 2008 Mar;25(3):616-24. doi: 10.1007/s11095-007-9405-2. Epub 2007 Aug 17.

    PMID: 17703345BACKGROUND
  • Yamazaki Y, Umino M, Fukayama H, Shimada M. The effect of alternating current iontophoresis on rats with the chronic constriction injury to the infraorbital nerve. Int J Dent. 2012;2012:405292. doi: 10.1155/2012/405292. Epub 2012 May 23.

    PMID: 22675357BACKGROUND
  • Kandell ER, Schwartz JH, Jessell TM. Principles of neural science 2000. 4th edition.

    BACKGROUND
  • Viscusi ER, Witkowski TA. Iontophoresis: the process behind noninvasive drug delivery. Reg Anesth Pain Med. 2005 May-Jun;30(3):292-4. doi: 10.1016/j.rapm.2004.12.002. No abstract available.

MeSH Terms

Interventions

LidocaineElectric Stimulation Therapy

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • alireza motealleh, PhD, PT

    Shiraz University of Medical Sciences

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Amin Kordi Yoosefinejad

Study Record Dates

First Submitted

June 15, 2015

First Posted

July 2, 2015

Study Start

January 1, 2013

Primary Completion

March 1, 2014

Study Completion

March 1, 2015

Last Updated

July 2, 2015

Record last verified: 2015-06

Locations